IMM 3.17% 30.5¢ immutep limited

encouraging progress !, page-25

  1. 59 Posts.
    lightbulb Created with Sketch. 31
    From the presentation, the comparison with existing approaches caught my attention, especially seeing as the combo being tested (Efti + pembro) is chemo free. Seems to outperform nicely in both types of cancer. So better efficacy and lower toxicity. Looks encouraging.

    https://hotcopper.com.au/data/attachments/2199/2199333-4b8e253d12f95ecfeda8f05d2e5409e7.jpg


    https://hotcopper.com.au/data/attachments/2199/2199335-79599236a165a248ccb833524711e969.jpg

 
watchlist Created with Sketch. Add IMM (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.